ADC Therapeutics SA
ADCT
$1.89
$0.2011.83%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -38.60M | -30.73M | -43.97M | -36.54M | -46.61M |
| Total Depreciation and Amortization | 801.00K | 793.00K | 802.00K | 838.00K | 843.00K |
| Total Amortization of Deferred Charges | 191.00K | -557.00K | 516.00K | 440.00K | 503.00K |
| Total Other Non-Cash Items | 10.79M | -1.39M | 9.07M | 7.24M | 11.09M |
| Change in Net Operating Assets | -29.52M | 10.03M | 8.54M | -4.82M | -9.92M |
| Cash from Operations | -56.33M | -21.85M | -25.04M | -32.85M | -44.10M |
| Capital Expenditure | -264.00K | -90.00K | -216.00K | -30.00K | -531.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -264.00K | -90.00K | -216.00K | -30.00K | -531.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 271.00K | 43.00K | -- | 98.70M | 356.00K |
| Repurchase of Common Stock | -- | -1.16M | -879.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 271.00K | -1.12M | -879.00K | 98.70M | 356.00K |
| Foreign Exchange rate Adjustments | 161.00K | -343.00K | 291.00K | 12.00K | -43.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -56.17M | -23.41M | -25.85M | 65.83M | -44.31M |